GO category | Enriched GO term | GO term p-valuea | GO term-associated gene products | |
---|---|---|---|---|
Up-regulatedb | Down-regulatedb | |||
GO:0035634 | Response to stilbenoid | <0.001 | Ifit3, Usp18 | - |
GO:0019785 | ISG15-specific protease activity | <0.001 | Usp18 | - |
GO:0032020 | ISG15-protein conjugation | <0.001 | Usp18 | - |
GO:0001823 | Mesonephros development | 0.001 | Osr2, Gpc3 | - |
GO:0033687 | Osteoblast proliferation | 0.002 | Osr2, Eif2ak2 | - |
GO:0035116 | Embryonic hindlimb morphogenesis | 0.003 | Osr2, Gpc3 | - |
GO:2000543 | Positive regulation of gastrulation | 0.008 | Osr2 | - |
GO:0061029 | Eyelid development in camera-type eye | 0.008 | Osr2 | - |
GO:0060272 | Embryonic skeletal joint morphogenesis | 0.008 | Osr2 | - |
GO:0048793 | Pronephros development | 0.008 | Osr2 | - |
GO:0030282 | Bone mineralization | 0.013 | Osr2, Gpc3 | - |
GO:0001656 | Metanephros development | 0.013 | Osr2, Gpc3 | - |
GO:0042474 | Middle ear morphogenesis | 0.020 | Osr2 | - |
GO:0004221 | Ubiquitin thiolesterase activity | 0.020 | Usp18 | - |
GO:0035115 | Embryonic forelimb morphogenesis | 0.030 | Osr2 | - |
GO:0030501 | Positive regulation of bone mineralization | 0.030 | Osr2 | - |
GO:0048523 | Negative regulation of cellular process | 0.036 | Slfn1, Gpc3, Ppap2b, Eif2ak2, Osr2 | Acaa2, Ddit4 |
GO:0030163 | Protein catabolic process | 0.042 | Usp18, Gpc3 | - |
GO:0050678 | Regulation of epithelial cell proliferation | 0.042 | Osr2, Gpc3 | - |
GO:0043401 | Steroid hormone mediated signaling pathway | 0.042 | - | Nr1d2 |